Co-Diagnostics Announces Key Financial Results and Strategic Advancements for 2025 Co-Diagnostics, Inc. reports significant financial outcomes for 2025 with strategic plans for commercialization. Read about their advancements and challenges.

Co-Diagnostics Announces Key Financial Results and Strategic Advancements for 2025 #USA #AI_Integration #Salt_Lake_City #Co-Diagnostics #PCR_platform

Co-Diagnostics to Showcase Innovative Healthcare Solutions at Medical Korea 2026 Co-Diagnostics will present its groundbreaking PCR platform at Medical Korea 2026 in Seoul, enhancing global healthcare collaborations amidst 6,000 attendees.

Co-Diagnostics to Showcase Innovative Healthcare Solutions at Medical Korea 2026 #South_Korea #Seoul #Co-Diagnostics #PCR_platform #Medical_Korea

Co-Diagnostics Introduces Innovative PCR Platform at World Health Expo in Dubai Co-Diagnostics, Inc. will showcase its proprietary PCR platform at the World Health Expo Labs in Dubai, enhancing molecular diagnostics in MENA.

Co-Diagnostics Introduces Innovative PCR Platform at World Health Expo in Dubai #Dubai #UAE #Co-Diagnostics #PCR_platform #CoMira_Diagnostics

Co-Diagnostics Joint Venture CoSara Achieves ISO 13485 Certification for Future PCR Test Production Co-Diagnostics' joint venture, CoSara, has received ISO 13485 certification in India as it prepares to manufacture its new PCR testing platform, marking a significant milestone.

Co-Diagnostics Joint Venture CoSara Achieves ISO 13485 Certification for Future PCR Test Production #India #Co-Diagnostics #CoSara #Vadodara #PCR_platform